[Effectiveness of using Intal on children with asthmatic bronchitis and bronchial asthma]. 1979

V M Sydel'nykov, and O I Lasytsia, and M M Sriebnyĭ

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D012138 Respiratory Therapy Care of patients with deficiencies and abnormalities associated with the cardiopulmonary system. It includes the therapeutic use of medical gases and their administrative apparatus, environmental control systems, humidification, aerosols, ventilatory support, bronchopulmonary drainage and exercise, respiratory rehabilitation, assistance with cardiopulmonary resuscitation, and maintenance of natural, artificial, and mechanical airways. Inhalation Therapy,Therapy, Inhalation,Therapy, Respiratory,Inhalation Therapies,Respiratory Therapies,Therapies, Inhalation,Therapies, Respiratory
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004205 Cromolyn Sodium A chromone complex that acts by inhibiting the release of chemical mediators from sensitized MAST CELLS. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack. Disodium Cromoglycate,Sodium Cromoglycate,Aarane,Bicromat Spray,Cromoglicic Acid,Cromoglycate,Cromoglycic Acid,Cromolyn,FPL-670,Intal,Lomudal,Nalcrom,Nasalcrom,Opticrom,Vicrom,Acid, Cromoglicic,Acid, Cromoglycic,Cromoglycate, Disodium,Cromoglycate, Sodium,FPL 670,FPL670
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

V M Sydel'nykov, and O I Lasytsia, and M M Sriebnyĭ
August 1963, Virginia medical monthly,
V M Sydel'nykov, and O I Lasytsia, and M M Sriebnyĭ
November 1977, Pediatriia,
V M Sydel'nykov, and O I Lasytsia, and M M Sriebnyĭ
February 1961, The Illinois medical journal,
V M Sydel'nykov, and O I Lasytsia, and M M Sriebnyĭ
January 1983, Nihon rinsho. Japanese journal of clinical medicine,
V M Sydel'nykov, and O I Lasytsia, and M M Sriebnyĭ
February 1986, Minerva pediatrica,
V M Sydel'nykov, and O I Lasytsia, and M M Sriebnyĭ
June 1955, Therapie der Gegenwart,
V M Sydel'nykov, and O I Lasytsia, and M M Sriebnyĭ
January 1984, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
V M Sydel'nykov, and O I Lasytsia, and M M Sriebnyĭ
October 1977, Voenno-meditsinskii zhurnal,
V M Sydel'nykov, and O I Lasytsia, and M M Sriebnyĭ
August 1969, Arerugi = [Allergy],
Copied contents to your clipboard!